MétaCan
Menu
Back to cohort
Record W4413951004 · doi:10.1158/1541-7786.mcr-25-0475

Cancer Genomic Alterations and Microenvironmental Features Encode Synergistic Interactions with Disease Outcomes

2025· article· en· W4413951004 on OpenAlexafffund
Masroor Bayati, Zoe P. Klein, Alexander T. Bahcheli, Mykhaylo Slobodyanyuk, Jeffrey To, Kevin C.L. Cheng, Jyoti Mishra, Diogo Pellegrina, Kissy Guevara‐Hoyer, Chris McIntosh, Mamatha Bhat, Jüri Reimand

Bibliographic record

VenueMolecular Cancer Research · 2025
Typearticle
Languageen
FieldMedicine
TopicFerroptosis and cancer prognosis
Canadian institutionsPrincess Margaret Cancer CentreResearch CanadaUniversity Health NetworkUniversity of TorontoOntario Institute for Cancer Research
FundersNatural Sciences and Engineering Research Council of CanadaCanadian Institutes of Health ResearchGovernment of OntarioTerry Fox Research InstituteUniversity of TorontoOntario Institute for Cancer Research
KeywordsTumor microenvironmentImmune systemBiologyCancerCarcinogenesisImmunotherapyCancer researchTumor progressionComputational biologyEpigenomicsGenomicsDiseaseCancer immunotherapyContext (archaeology)Cancer immunologyBreast cancerBioinformaticsImmunologyGenomeGeneDNA methylationMedicineGeneticsGene expressionInternal medicine

Abstract

fetched live from OpenAlex

Oncogenesis, tumor progression, and therapy response are shaped by somatic alterations in the cancer genome and features of the tumor-immune microenvironment (TME). How interactions between these two systems influence tumor evolution and clinical outcomes remains incompletely understood. To address this challenge, we developed the multi-omics analysis framework PACIFIC that systematically integrates genetic cancer drivers and infiltration profiles of immune cells to find pairwise combinations of drivers and TME characteristics that jointly associate with clinical outcomes. By analyzing 8,500 primary tumor samples of 26 cancer types, we report 34 immunogenomic interactions (IGX) in 13 cancer types in which context-specific combinations of genomic alterations and immune cell levels were significantly correlated with patient survival. Subsets of tumor samples defined by some IGXs were characterized by tumor-intrinsic and microenvironmental metrics of immunogenicity and differential expression of immunotherapy target genes. In luminal-A breast cancer, an IGX involving MEN1 deletion combined with reduced levels of neutrophils associated with lower progression-free survival and deregulation of immune signaling pathways, as observed in two independent cancer genomics datasets. These results showcase the ability of PACIFIC to integrate complex multi-omics datasets with clinical information, enabling the identification of clinically relevant IGXs. Such interactions provide a rich set of hypotheses for mechanistic studies and the development of biomarkers and therapeutic targets. IMPLICATIONS: Co-occurrence patterns of cancer drivers and TME characteristics highlight synergistic interactions with prognostic potential.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.005

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0020.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.001
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.026
GPT teacher head0.382
Teacher spread0.357 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueMolecular Cancer ResearchSame topicFerroptosis and cancer prognosisFrench-language works237,207